10
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Transcriptional modulation of hepatocyte nuclear factor 4a (HNF-4a) and/or peroxisome proliferator-activated receptor a (PPARa)-controlled genes by low molecular weight compounds

Pages 141-144 | Published online: 25 Feb 2005

Reference

  • BAR-TANA J et al.: Inhibition of lipid synthesis by 0, 0' tetramethyl-substituted C14-C22 a, o) di-carboxylic acids in the rat in vivo. J. Biol. Chem. (1985) 260:8404–8410.
  • KAHN-ROSE G et al.: Inhibition of lipid synthesis by 0, 0' tetramethyl-substituted C14-C22 a, dicarboxylic acids in cultured rat hepatocytes. I. Biol. Chem. (1985) 260:8411–8415.
  • BAR-TANA J et al.: The hypolipidemic effect of 0, 13'-methyl-substituted hexadecanedioic acid in normal and nephrotic rats. J. Lipid Res. (1998) 29:431–441.
  • FRENKEL B et al.: The hypochylomicronemic effect of 0, 13'-methyl-substituted hexadecanedioic acid is mediated by a decrease in apolipoprotein C-III. J. Biol. Chem. (1988) 263:8491–8497.
  • TZUR R et al.: The hypolipidemic antiobesity and hypoglycemic-hypoinsulinemic effects of O, 13'-methyl-substituted hexadecanedioic acid in sand rats. Diabetes (1988) 37:1618–1624.
  • TZUR R et al.: Adipose reduction by 0, 0'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16). Intern. J. Obesity (1989) 13:313–326.
  • BAR-TANA J et al.: Synthesis, hypolipidemic and anti-diabetogenic activities of 13, 13'-tetra-substituted, long chain dioic acids. J. Med. Chem. (1989) 32:2072–2084.
  • BAR-TANA J et al.: Long chain di-carboxylic acids: hypolipidemic, antiobesity and antidiabetic activity. In: New Antidiabetic Drugs. Bailey CJ, Flatt PR (Eds.), Smith-Gordon & Co., UK (1990).
  • RUSSEL JC et al.: The hypolipidemic effect of 0, 0'-tetramethylhexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats. Arterioscler. Thromb. (1991) 11:602–609.
  • KALDERON B et al.: Tissue selective modulation of redox and phosphate potentials by 13, 13'-methyl-substituted hexadecanedioic acid. Endocrinology (1992) 131:1629–1635.
  • MAYOREK N et al.: Hypocholesterolemic effect of 0, I3'-methyl-substituted hexadecanedioic acid in the male hamster. Biochem. J. (1993) 289:911–917.
  • FRENKEL B et al.: The effect of 0, 13'-methyl-substituted hexadecanedioic acid on plasma VLDL metabolism in rats: role of apolipoproteinBiochem. J. (1994)298:409–414.
  • MAYOREK N et al.: Sensitization to insulin induced by 13, 13'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo. Diabetes (1997) 46:1958–1964.
  • HERMESH O et al.: Mitochondria un-coupling by a long chain fatty acyl analogue. J. Biol. Chem. (1998) 273:4237–4244.
  • RUSSEL JC et al.: Inhibition of athero-sclerosis and myocardial lesions in the JCR:LA-cp rat by 0, W-tetra-methyl hexadecanedioic acid. Arterioscler. Thromb. Vasc. Biol. (1995) 15:918–923.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.